Diseases & Disorders
(G83)
IRS Verified
DX Registered
990 on File
ALZHEIMERS DISEASE AND RELATED DISORDERS NEW YORK CITY INC
Financial strength (30%)
64/100
Reliability (20%)
50/100
Effectiveness (25%)
80/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
The mission of CaringKind* is to create, deliver, and promote comprehensive and compassionate care and support services for individuals and families affected by Alzheimer’s disease and related dementias, and to eliminate Alzheimer’s disease through the advancement of research. We achieve our mission by providing programs and services for individuals with dementia, their family and professional caregivers; increasing public awareness; collaborating with research centers; and informing public policy through advocacy.
Financial Overview — FY 2025
$5.8M
Total Revenue
$6.3M
Total Expenses
$7.3M
Net Assets
44
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
72.1%
Fundraising Efficiency
222.6%
Operating Reserve
13.92x
Liability-to-Asset
23.4%
Revenue Diversification
92.8%
Executive Compensation
$487K
Compared with Peers
FY 2025
Compared with 264 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
72.1% | 83.2% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
11.3% | 11.0% |
P10P90
|
Below median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
16.6% | 2.5% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
222.6% | 112.2% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.9 mo | 12.5 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
23.4% | 12.5% |
P10P90
|
Below median |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
92.8% | 87.6% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
-39.3% | 7.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
6.5% | 5.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-7.7% | 4.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $5.8M | $6.3M | $7.3M | 72.1% | 44 |
| 2024 | $9.6M | $5.9M | $7.6M | 72.4% | 42 |
| 2023 | $5.6M | $5.2M | $3.7M | 71.7% | 35 |
| 2022 | $6.2M | $4.9M | $3.4M | 74.2% | 30 |
| 2021 | $4.9M | $4.1M | N/A | — | 33 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.